News

Greenphire, the global leader in financial lifecycle management for clinical trials, today announced that it is hosting its inaugural patient convenience summit on Oct. 20, 2021, featuring highly regarded industry leaders, sponsors, CROs, sites and patients. The half-day event...

Gerresheimer AG further accelerated its revenue growth in the third quarter of 2021. “The third quarter once again shows the success of our growth strategy. The strong and further rising demand for our innovative and sustainable solutions proves our...

The Chiesi Research Centre celebrates its 10th anniversary. The Group’s main research hub covers 20,000 square metres, a building which was inaugurated in October 2011 in Parma following a €90 million investment. The Centre houses 638 people, 498 of whom...

Enesi Pharma has entered into an agreement with the US National Institutes of Health's (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to test a novel ImplaVax enabled pandemic flu vaccine. ImplaVax-enabled vaccination products leverage Enesi's innovative unit solid-dose,...

Silence Therapeutics and Hansoh Pharmaceutical have entered a partnership to develop small-interfering ribonucleic acid (siRNAs) drugs for three undisclosed targets using the former’s mRNAi GOLD platform. Following the conclusion of the Phase I clinical trial, Hansoh will hold an exclusive...

Antios Therapeutics, Inc. and Assembly Biosciences, Inc. announced that the companies have entered into a clinical collaboration agreement to evaluate a triple combination treatment in patients with chronic hepatitis B virus (HBV) infection. A single cohort in the ongoing...

Moleculin Biotech has obtained the UK Medicines and Healthcare Products Regulatory Agency (MHRA) authorisation to initiate a Phase Ia clinical trial of its drug, WP1122, in the country to treat Covid-19. An inhibitor of metabolism/glycosylation, WP1122 is a prodrug of...